Elevated levels of circulating intercellular adhesion molecule 1 and tumor necrosis factor a in the serum of children vertically infected with HIV-1

Pediatric AIDS and HIV Infection

Volumn 7, Issue 6, 1996, Pages 413-417

  Obregön, Eva ^a   Börner, Cristina ^a   Navarro, Joaqum ^a   Gurbindo, Dolores ^a   Fernândez Cruz, Eduardo ^a   Munoz Fernandez, Angeles ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; ZIDOVUDINE;

ADOLESCENT; ARTICLE; BLOOD; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CHILD; DISEASE TRANSMISSION; FEMALE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INFANT; MALE; METABOLISM; PRESCHOOL CHILD;

ADOLESCENT; ANTI-HIV AGENTS; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INTERCELLULAR ADHESION MOLECULE-1; MALE; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA; ZIDOVUDINE;

EID: 0030334695     PISSN: 10455418     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Turner BJ, Eppers S, Mckee LJ, et al., A population-based comparison of the clinical course of children and adults with AIDS. AIDS 1995; 9:65-72.
2. Duliege AM, Messiah A, Blanches S, et al., Natural history of human immunodeficiency virus type 1 infection in children: prognostic value of laboratory tests on the bimodal progression of the disease. Pediatr Infect Dis J 1992; 11:630-5.
3. Turner BJ, Denison M, Eppes SC, et al., Survival experience of 789 children with the acquired immunodeficiency syndrome. Pediatr Infect Dis J 1993; 12:310-20.
4. Scott GB, Hutto C, Makuch RW, Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. N Engl J Med 1989; 321:1791-6.
5. Munoz A, Want MC, Bass S, et al., Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Am J Epidemiol 1989; 130:530-9.
6. Poli G, Kinter A, Justement JS, et al., Tumor necrosis factor- functions in an automne manner in the induction of human immunodeficiency virus expression. Proc Natl Acad Sei USA 1990; 87:782-5.
7. Brown CC, Poli G, Lubaki N, et al., Elevated levels of tumor necrosis factor-a in Zairian neonate plasmas: implications for perinatal infection with the human immunodeficiency virus. J Infect Dis 1994; 169:975-80.
8. Sydow VM, Sonnerborg A, Gaines H, et al., Interferon-a and tumor necrosis factor-a in serum of patients in various stages of HIV-1 infection. AIDS Res Hum Retroviruses 199; 7:375-80.
9. Mintz M, Rapaport R, Oleske JM, et al., Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome. Am J Dis Child 1989; 143:771-4.
10. Tsujisaki M, Imai K, Hirata H, et al., Detection of circulating intercellular molecule-1 antigen in malignant diseases. Clin Exp Immunol 1991;85:3-8.
11. Harning R, Mainolfi E, Bystryn J-C, et al., Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res 1992;51:5003-5.
12. Most J, Zangerle R, Herold M, et al., Elevated concentration of circulating intercellular adhesion molecule 1 (ICAM-1) in HIV1 infection. J Acquir Immune Defic Syndr 1993;6:221-6.
13. Puppo FS, Brenci M, Scudeletti M, et al., Elevated serum levels of circulating intercellular adhesion molecule-1 in HIV infection. AIDS 1993;7:593-4.
14. Bevilacqua MP, Endothelial-leukocyte adhesion molecules. Ann Rev Immunol 1993; 11:767-804.
15. Center for Disease Control and Prevention, 1994 revised classification system for HIV-1 infection in children less than 13 years of age. MMWR 1994; 43:1-13.
16. Navarro J, Pizarro A, Fernândez-Cruz E, et al., Pentoxifylline preferentially inhibits interleukin-10 production by HIV-1 infected human T cells. AIDS 1994; 8:192-41.
17. Munoz-Fernândez MA, Navarro J, Garcia Montes M, et al., Quantification of low levels of HIV-1 RNA viremia in p24-antigen-negative asymptomatic HIV+ patients by use of the polymerase chain reaction. J Clin Microbiol 1995;34:404-8.
18. Albert J, Fenyo EM, Simple sensitive, and specific detection of human immunodeficiency virus type 1 in clinical specimens by polymerase chain reaction with nested primers. J Clin Microbiol 1990; 28:1560-4.
19. Scott-Algara D, Vuillier F, Marasescu M, Serum levels of IL-2, IL-l-a, TNF-a, and soluble receptor of IL-2 in HIV-1 infected patients. AIDS Res Hum Retroviruses 1991; 7:381-6.
20. Lahdevirta J, Maury CPJ, Teppo AM, et al., Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 1988; 85:289-91.
21. Arditi M, Kabat W, Yogev R, Serum tumor necrosis factor-alpha, interleukin 1-beta, p24 antigen concentrations and CD4+ cells at various stages of HIV-1 infection in children. Pediatr Infect Dis J 1991; 10:450-5.
22. Ellaurie M, Rubinstein A, Tumor necrosis factor-a in pédiatrie HIV-1 infection. AIDS 1992; 6:1265-8.
23. Cremoni L, Vaira LL, D'Amico P, et al., Does zidovudine reduce tumor necrosis factor-a in HIV-1 positive patients? AIDS 1993; 7:128-9.
24. Meyer DM, Dustin ML, Carron CP, Characterization of intercellular adhesion molecule-1 ectodomain (SICAM) as an inhibitor of lymphocyte function-associated molecule-1 interaction with ICAM-1. J Immunol 1995; 155:3578-84.
25. Okamoto T, Matsuyama T, Mori S et al., Augmentation of human immunodeficiency virus type 1 gene expression by tumor necrosis factor-a. AIDS Res Hum Retroviruses 1989; 5:131-8.
26. Duch EJ, Maury WJ, Fouks TM, et al., Necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-B sites in the long terminal repeat. Proc Natl Acad Sei USA 1989; 86:5974-8.